Anterix (NASDAQ:ATEX) Price Target Increased to $100.00 by Analysts at Craig Hallum
Anterix (NASDAQ:ATEX) had its price objective lifted by equities researchers at Craig Hallum from $80.00 to $100.00 in a research note issued to investors on Monday, The Fly reports. The firm currently has a “buy” rating on the stock. Craig Hallum’s price objective points to a potential upside of 120.56% from the company’s previous close.
A number of other research firms also recently commented on ATEX. Zacks Investment Research downgraded shares of Anterix from a “hold” rating to a “sell” rating in a research report on Tuesday, June 23rd. B. Riley boosted their price objective on shares of Anterix from $59.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Finally, BidaskClub cut Anterix from a “sell” rating to a “strong sell” rating in a research report on Saturday. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. Anterix currently has a consensus rating of “Hold” and an average target price of $68.17.
ATEX opened at $45.34 on Monday. The company has a quick ratio of 16.11, a current ratio of 16.11 and a debt-to-equity ratio of 0.03. The stock’s fifty day moving average is $53.15 and its two-hundred day moving average is $47.46. The company has a market capitalization of $777.92 million, a P/E ratio of -20.06 and a beta of 0.36. Anterix has a 52 week low of $29.38 and a 52 week high of $57.75.
In related news, CFO Timothy Gray sold 2,094 shares of the business’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of $58.18, for a total transaction of $121,828.92. Following the transaction, the chief financial officer now directly owns 57,957 shares in the company, valued at approximately $3,371,938.26. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Thomas Clark Akers sold 4,000 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $52.55, for a total value of $210,200.00. Following the transaction, the director now directly owns 11,895 shares in the company, valued at $625,082.25. The disclosure for this sale can be found here. Insiders have sold 12,876 shares of company stock valued at $697,544 in the last three months. 6.74% of the stock is currently owned by corporate insiders.
Several hedge funds have recently modified their holdings of the company. Rhumbline Advisers raised its position in shares of Anterix by 3.6% in the 4th quarter. Rhumbline Advisers now owns 12,943 shares of the company’s stock valued at $559,000 after purchasing an additional 445 shares during the last quarter. Swiss National Bank increased its stake in Anterix by 3.8% during the 4th quarter. Swiss National Bank now owns 24,450 shares of the company’s stock valued at $1,056,000 after purchasing an additional 900 shares in the last quarter. State Street Corp acquired a new position in Anterix during the 4th quarter valued at approximately $9,976,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Anterix by 4.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 70,513 shares of the company’s stock worth $3,047,000 after buying an additional 2,755 shares during the last quarter. Finally, Bank of Montreal Can lifted its stake in shares of Anterix by 30.1% during the fourth quarter. Bank of Montreal Can now owns 1,881 shares of the company’s stock worth $81,000 after buying an additional 435 shares during the period.
Anterix Company Profile
Anterix Inc operates as a wireless communications company. The company focuses on enabling private broadband connectivity for critical infrastructure and enterprise businesses. It holds licensed spectrum in the 900 MHz band with nationwide coverage throughout the United States, Hawaii, Alaska, and Puerto Rico.
Further Reading: What causes a yield curve to invert?
Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.